Preoperative Use of Multiple Advanced Therapies Is Not Associated With Endoscopic Inflammatory Pouch Diseases
Inflammatory Bowel Diseases · 2024
DOI: 10.1093/ibd/izad054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2024. Verfasst von Joseph Carter Powers und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA. Hauptthemen laut MEDLINE: Colonic Pouches, Pouchitis, Proctocolectomy, Restorative, Colitis, Ulcerative. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH.
Abstract (Originalsprache)
Background
Patients with an ileal pouch-anal anastomosis (IPAA) can experience pouch inflammation postoperatively. The use of antitumor necrosis factor (anti-TNF) biologics may be associated with pouch inflammation, but limited data exist on the impact of multiple advanced therapies on development of subsequent pouch inflammation. The aim of this study was to assess for an association between preoperative use of multiple advanced therapies and risk of endoscopically detected inflammatory pouch diseases (EIPDs).
Methods
We performed a retrospective analysis of ulcerative colitis (UC) and indeterminate colitis (IBDU) patients who underwent an IPAA at a quaternary care center from January 2015 to December 2019. Patients were grouped based on number and type of preoperative drug exposures. The primary outcome was EIPD within 5 years of IPAA.
Results
Two hundred ninety-eight patients were included in this analysis. Most of these patients had UC (95.0%) and demonstrated pancolonic disease distribution (86.1%). The majority of patients were male (57.4%) and underwent surgery for medically refractory disease (79.2%). The overall median age at surgery was 38.6 years. Preoperatively, 68 patients were biologic/small molecule-naïve, 125 received anti-TNF agents only, and 105 received non-anti-TNF agents only or multiple classes. Ninety-one patients developed EIPD. There was no significant association between type (P = .38) or number (P = .58) of exposures and EIPD, but older individuals had a lower risk of EIPD (P = .001; hazard ratio, 0.972; 95% confidence interval, 0.956-0.989).
Conclusion
Development of EIPD was not associated with number or type of preoperative advanced therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
- Department of Gastroenterology, Hepatology, and Nutrition, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, OH, USA.
- Division of Gastroenterology and Hepatology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
- Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland, OH, USA.
- Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA.
- Department of Colon and Rectal Surgery, Cleveland Clinic, Cleveland, OH, USA.
ORCID-Profile: Joseph Carter Powers, Stefan Holubar, Taha Qazi
Förderung
- NIDDK NIH HHS
- NIH
Zitieren
APA
Powers, J. C., Cohen, B. L., Rieder, F., Click, B. H., Lyu, R., Westbrook, K., Hull, T., Holubar, S., Regueiro, M. D., & Qazi, T. (2024). Preoperative Use of Multiple Advanced Therapies Is Not Associated With Endoscopic Inflammatory Pouch Diseases. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izad054
Vancouver
Powers JC, Cohen BL, Rieder F, Click BH, Lyu R, Westbrook K, et al. Preoperative Use of Multiple Advanced Therapies Is Not Associated With Endoscopic Inflammatory Pouch Diseases. Inflammatory Bowel Diseases. 2024. doi:10.1093/ibd/izad054
BibTeX
@article{Powers2024,
author = {Powers, Joseph Carter and Cohen, Benjamin L and Rieder, Florian and Click, Benjamin H and Lyu, Ruishen and Westbrook, Katherine and Hull, Tracy and Holubar, Stefan and Regueiro, Miguel D and Qazi, Taha},
title = {Preoperative Use of Multiple Advanced Therapies Is Not Associated With Endoscopic Inflammatory Pouch Diseases},
journal = {Inflammatory Bowel Diseases},
year = {2024},
doi = {10.1093/ibd/izad054}
}
EUVIMED